OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
GHRP, selective ghrelin receptor agonist. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported | 100 mcg | 1–2× daily | 0.12 mL | 12 u | 50 doses | |
| Standard | 200 mcg | 1–3× daily | 0.24 mL | 24 u | 25 doses | |
| Upper reported | 300 mcg | 1–3× daily | 0.36 mL | 36 u | 16 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 100 mcg | daily | 0.12 mL | 12 u | 14 | 1.4 mg |
| Weeks 3–4 | 200 mcg | daily | 0.24 mL | 24 u | 14 | 2.8 mg |
| Week 5 onward per 4 weeks from here on |
300 mcg | daily | 0.36 mL | 36 u | 28 | 8.4 mg |
The most receptor-selective of the GHRP family — releases GH with minimal effect on cortisol, ACTH or prolactin, which is its main pharmacological point of interest. Human pharmacology work exists; long-term human efficacy trials do not.
Buy Ipamorelinthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
An AMPK-activating nucleoside studied for ischaemia protection and as an exercise mimetic in preclinical research. Requires very l…
A tetra-substituted GHRH(1-29) analogue without the drug affinity complex, giving a short pulse rather than sustained elevation. F…
Every compound compared in one table: dose range, how often, half-life and evidence tier.